Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Efficacy and safety of adjuvant therapy with PD‑1/PD‑L1 inhibitors in cancer.

Subjects: *PROGRAMMED cell death 1 receptors; *PROGRAMMED death-ligand 1; *RENAL cell carcinoma

  • Source: Experimental & Therapeutic Medicine. Dec2022, Vol. 24 Issue 6, pN.PAG-N.PAG. 1p.

Record details

×
  • 1-10 of  32 results for ""Programmed death-ligand 1""